Tag: NASDAQ:ATRA

Atara Biotherapeutics Inc (NASDAQ: ATRA)’s stock price has soared by 22.19 in relation to previous closing price of 11.67. Nevertheless, the company has seen a

The 36-month beta value for ATRA is at 0.45. Analysts have varying views on the stock, with 1 analysts rating it as a “buy,” 3

The stock has a 36-month beta value of 0.51. Opinions on the stock are mixed, with 1 analysts rating it as a “buy,” 3 as